LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
1-Year Est. Return 2.97%
This Quarter Est. Return
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$116M
AUM Growth
+$4.77M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
16
New
Increased
Reduced
Closed

Top Buys

1
+$26.1M
2
+$3.74M
3
+$2.2M
4
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$1.97M
5
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$1.39M

Top Sells

1
+$10.6M
2
+$4.58M
3
+$4.22M
4
IMUX icon
Immunic
IMUX
+$3.39M
5
OTIC
Otonomy, Inc.
OTIC
+$682K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$26.1M 22.61%
+2,825,976
2
$23M 19.87%
3,126,173
+69,753
3
$13.2M 11.43%
854,591
+241,520
4
$12.2M 10.54%
1,998,417
+323,740
5
$10.4M 8.97%
1,653,495
-672,338
6
$8.99M 7.78%
1,093,900
-1,288,227
7
$5.85M 5.06%
70,357
+26,418
8
$5.08M 4.39%
3,003,102
+727,370
9
$4.63M 4.01%
167,796
+30,175
10
$3.91M 3.38%
784,158
+279,296
11
$1.17M 1.01%
+114,557
12
$831K 0.72%
+64,739
13
$285K 0.25%
+25,325
14
– –
-7,898
15
– –
-1,072,288
16
– –
-2,312,880